American Journal of Ophthalmology
Volume 143, Issue 4 , Pages 635-641.e1 , April 2007

Profiles of Obesity, Weight Gain, and Quality of Life in Idiopathic Intracranial Hypertension (Pseudotumor Cerebri)

  • Anthony B. Daniels

      Affiliations

    • Departments of Neurology and Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Grant T. Liu

      Affiliations

    • Departments of Neurology and Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Nicholas J. Volpe

      Affiliations

    • Departments of Neurology and Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Steven L. Galetta

      Affiliations

    • Departments of Neurology and Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Mark L. Moster

      Affiliations

    • Departments of Neurology and Ophthalmology, Albert Einstein Medical Center, Wills Eye Hospital, Philadelphia, Pennsylvania
    • ,
  • Nancy J. Newman

      Affiliations

    • Departments of Ophthalmology and Neurology, Emory University School of Medicine, Atlanta, Georgia
    • ,
  • Valerie Biousse

      Affiliations

    • Departments of Ophthalmology and Neurology, Emory University School of Medicine, Atlanta, Georgia
    • ,
  • Andrew G. Lee

      Affiliations

    • Departments of Neurology and Ophthalmology, University of Iowa College of Medicine, Iowa City, Iowa
    • ,
  • Michael Wall

      Affiliations

    • Departments of Neurology and Ophthalmology, University of Iowa College of Medicine, Iowa City, Iowa
    • ,
  • Randy Kardon

      Affiliations

    • Departments of Neurology and Ophthalmology, University of Iowa College of Medicine, Iowa City, Iowa
    • ,
  • Marie D. Acierno

      Affiliations

    • Department of Ophthalmology, Louisiana State University Health Sciences Center, New Orleans, Louisiana
    • ,
  • James J. Corbett

      Affiliations

    • Departments of Neurology and Ophthalmology, University of Mississippi Medical Center, Jackson, Mississippi.
    • ,
  • Maureen G. Maguire

      Affiliations

    • Departments of Ophthalmology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Laura J. Balcer

      Affiliations

    • Departments of Neurology and Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • Corresponding Author InformationInquiries to Laura J. Balcer, Department of Neurology, University of Pennsylvania School of Medicine, 3 East Gates Building, 3400 Spruce Street, Philadelphia, PA 19104

,Accepted 30 December 2006.

References 

  1. Smith JL. Whence pseudotumor cerebri?. J Clin Neuroophthalmol. 1985;5:55–56
  2. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59:1492–1495
  3. Crock PA, McKenzie JD, Nicoll AM, et al. Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand. Acta Paediatr. 1998;87:381–386
  4. Foley J. Benign forms of intracranial hypertension: “toxic” and “otitic” hydrocephalus. Brain. 1955;78:1–41
  5. Bulens C, DeVries WAEJ, Van Crevel H. Benign intracranial hypertension. J Neurol Sci. 1979;40:147–157
  6. Wysowski DK, Green L. Serious adverse events in Norplant users reported to the food and drug administration’s MedWatch spontaneous reporting system. Obstet Gynecol. 1995;85:538–542
  7. Digre KB, Corbett JJ. Idiopathic intracranial hypertension (Pseudotumor cerebri): a reappraisal. Neurologist. 2001;7:2–67
  8. Chiu AM, Chuenkongkaew WL, Cornblath WT, et al. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol. 1998;126:116–121
  9. Valentine GH. Triamcinolone and intracranial hypertension: a side effect. Lancet. 1959;1:892
  10. Neville BG, Wilson J. Benign intracranial hypertension following corticosteroid withdrawal in childhood. Br Med J. 1970;3:554–556
  11. Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology. 1991;41:239–244
  12. Shin RK, Balcer LJ. New developments in idiopathic intracranial hypertension. Curr Neurol Neurosci Reports. 2001;1:463–470
  13. Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana. Arch Neurol. 1988;45:875–877
  14. Carta A, Bertuzzi F, Cologno D, Giorgi C, Montanari E, Tedesco S. Idiopathic intracranial hypertension (pseudotumor cerebri): descriptive epidemiology, clinical features, and visual outcome Parma, Italy, 1990 to 1999. Eur J Ophthalmol. 2004;14:48–54
  15. Wall M, George AE. Idiopathic intracranial hypertension: a prospective study of 50 patients. Brain. 1991;114:155–180
  16. Kleinschmidt JJ, Digre KB, Hanover R. Idiopathic intracranial hypertension (Relationship to depression, anxiety, and quality of life). Neurology. 2000;54:319–324
  17. Mangione CM. The National Eye Institute 25-Item Visual Function Questionnaire Scoring Algorithm, 2000. http://www.nei.nih.gov/resources/visionfunction/manual_cm2000.pdf.
  18. Mangione CM, Berry S, Spritzer K, et al. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol. 1998;116:227–233
  19. Mangione CM, Lee PP, Pitts J, et al. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Arch Ophthalmol. 1998;116:1496–1504
  20. Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-Item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050–1058
  21. Ware JE, Kosinski M. SF-36 Physical and Mental Health Summary Scales: a manual for users of version 1. 2nd ed.. Lincoln, RI: QualityMetric Incorporated; 2001;
  22. Ireland B, Corbett JJ, Wallace RB. The search for causes of idiopathic intracranial hypertension (A preliminary case-control study). Arch Neurol. 1990;47:315–320
  23. Subramanian PS, Goldenberg-Cohen N, Shukla S, Cheskin LJ, Miller NR. Plasma ghrelin levels are normal in obese patients with idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 2004;138:109–113
  24. Johnson LN, Krohel GB, Madsen RW, March GA. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998;105:2313–2317
  25. Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol. 2005;6:29–37
  26. Lee AG. Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne. Cutis. 1995;55:165–168

 See accompanying Editorial on page 683.

PII: S0002-9394(07)00004-9

doi: 10.1016/j.ajo.2006.12.040

American Journal of Ophthalmology
Volume 143, Issue 4 , Pages 635-641.e1 , April 2007

Article Tools

* Image Usage & Resolution